that has faced criticism for agreeing to sell the vast majority of its output to the united states gilleo told d.w. that its face difficulty meeting demand and that it's planning to increase the production of ramdass of beer from the current 190000 batches per month to $2000000.00. future supplies the company says will be allocated on the basis of the number of new infections in a country. european policy makers have also been threatening to impose compulsory licensing on ram disappear this would allow other manufacturers to produce the drug under world trade organization rules such a move would be possible in the case of a national emergency. and we asked european parliamentarian peter lees why the e.u. might bypass the patent when the company insists it will deliver the drug. yes it will do it well but i'm not sure if it is not you know for the moment in the united in the european union the figures are quite low but we don't know what's going to happen and worldwide we have really a lot of hot spots where the outbreaks are huge and that's why i'm not sure if what is going to deliver wil